An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM

NCT07867886 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boston Scientific Corporation

Collaborators